JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patien

starstarstarstarstar

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

RSS Feed URL

Claim this podcast

Remove this podcast

Play Latest Episode:

Title: Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer

Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer

October 3rd, 2019

Interview with Ranhjit Manchanda, MD, author of A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer Go to Episode

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

September 12th, 2019

Interview with David J. Pinato, MD, author of Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy… Go to Episode

Women’s Representation Among Lead Investigators of Clinical Trials in Oncology

August 8th, 2019

Interview with Emma B. Holliday, MD, author of Women’s Representation Among Lead Investigators of Clinical Trials in Oncology Go to Episode

Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab

July 25th, 2019

Interview with Suzanne L. Topalian, author of Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small… Go to Episode